Ironwood Pharmaceuticals IRWD Secured lines of credit
Secured lines of credit at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LongTermLineOfCredit.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's secured lines of credit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's secured lines of credit?
- Ironwood Pharmaceuticals (IRWD) reported secured lines of credit of $385M in Q1 2026.
- How has Ironwood Pharmaceuticals's secured lines of credit changed year-over-year?
- Ironwood Pharmaceuticals's secured lines of credit decreased by 0.0% year-over-year, from $385M to $385M.
- What is the long-term trend for Ironwood Pharmaceuticals's secured lines of credit?
- Over 2 years (2023 to 2025), Ironwood Pharmaceuticals's secured lines of credit has grown at a 13.3% compound annual growth rate (CAGR), from $300M to $385M.